SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Boesen P, Sørensen SF. Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county: a prospective investigation, 1982–1985. Arthritis Rheum 1987; 30: 2949.
  • 2
    Machado EB, Michet CJ, Ballard DJ, Hunder GG, Beard CM, Chu CP, et al. Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota, 1950–1985. Arthritis Rheum 1988; 31: 7459.
  • 3
    Baldursson O, Steinsson K, Björnsson J, Lie JT. Giant cell arteritis in Iceland: an epidemiologic and histopathologic analysis. Arthritis Rheum 1994; 37: 100712.
  • 4
    Gran JT, Myklebust G. The incidence of polymyalgia rheumatica and temporal arteritis in the county of Aust Agder, south Norway: a prospective study 1987-94. J Rheumatol 1997; 24: 173943.
  • 5
    Haugeberg G, Paulsen PQ, Bie RB. Temporal arteritis in Vest Agder County in southern Norway: incidence and clinical findings. J Rheumatol 2000; 27: 26247.
  • 6
    Sproul E. A case of temporal arteritis (CPC). N Y State J Med 1942; 42: 3457.
  • 7
    McMillan G. Diffuse granulomatous aortitis with giant cells associated with partial rupture and dissection of the aorta. Arch Pathol 1950; 49: 639.
  • 8
    Magarey F. Dissecting aneurysm due to giant cell aortitis. J Pathol Bacteriol 1950; 62: 4456.
  • 9
    Reid J. Dilatation of the aorta due to granulomatous (giant cell) aortitis. Br Heart J 1957: 19; 20610.
  • 10
    Hamrin B. Polymyalgia arteritica. Acta Med Scand Suppl 1972; 533: 1131.
  • 11
    Oestberg G. Morphological changes in the large arteries in polymyalgia arteritica. Acta Med Scand Suppl 1972; 533: 13564.
  • 12
    Blockmans D, Stroobants S, Maes A, Mortelmans L. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med 2000; 108: 2469.
  • 13
    Evans JM, O'Fallon WM, Hunder GG. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis: a population-based study. Ann Intern Med 1995; 122: 5027.
  • 14
    Evans JM, Bowles CA, Björnsson J, Mullany CJ, Hunder GG. Thoracic aortic aneurysm and rupture in giant cell arteritis: a descriptive study of 41 cases. Arthritis Rheum 1994; 37: 153947.
  • 15
    Jennings G. Arteritis of the temporal vessels. Lancet 1938; 1: 4248.
  • 16
    Klein RG, Hunder GG, Stanson AW, Sheps SG. Large artery involvement in giant cell temporal arteritis. Ann Intern Med 1975; 83: 80612.
  • 17
    Brack A, Martinez-Taboada V, Stanson A, Goronzy JJ, Weyand CM. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum 1999; 42: 3117.
  • 18
    Caselli RJ, Hunder GG, Whisnant JP. Neurologic disease in biopsy-proven giant cell (temporal) arteritis. Neurology 1988; 38: 3529.
  • 19
    Andersson R, Malmvall BE, Bengtsson BA. Long-term survival in giant cell arteritis including temporal arteritis and polymyalgia rheumatica: a follow-up study of 90 patients treated with corticosteroids. Acta Med Scand 1986; 220: 3614.
  • 20
    Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG. The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med 1995; 123: 1924.
  • 21
    Matteson EL, Gold KN, Bloch DA, Hunder GG. Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort. Am J Med 1996; 100: 1936.
  • 22
    Gonzalez-Gay MA, Blanco R, Abraira V, Garcia-Porrua C, Ibanez D, Garacia-Pais MJ, et al. Giant cell arteritis in Lugo, Spain, is associated with low longterm mortality. J Rheumatol 1997; 24: 21716.
  • 23
    Uddhammar A, Eriksson AL, Nystrom L, Stenling R, Rantapaa-Dahlqvist S. Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden. J Rheumatol 2002; 29: 73742.
  • 24
    Nordborg E, Bengtsson BA. Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy. BMJ 1989; 299: 54950.
  • 25
    Nesher G, Sonnenblick M, Friedlander Y. Analysis of steroid related complications and mortality in temporal arteritis: a 15-year survey of 43 patients. J Rheumatol 1994; 21: 12836.
  • 26
    Bickerstaff LK, Pairolero PC, Hollier LH, Melton LJ, Van Peenen HJ, Cherry KJ, et al. Thoracic aortic aneurysms: a population-based study. Surgery 1982; 92: 11038.
  • 27
    Melton LJ III, Bickerstaff LK, Hollier LH, Van Peenen HJ, Lie JT, Pairolero PC, et al. Changing incidence of abdominal aortic aneurysms: a population-based study. Am J Epidemiol 1984; 120: 37986.
  • 28
    Melton LJ III. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996; 71: 26674.
  • 29
    Hunder G, Bloch D, Michel B, Stevens MD, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990; 33: 11228.
  • 30
    Nuenninghoff DM, Hunder GG, Christianson TJH, McClelland RL, Matteson EL. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum 2003; 48: 352231.
  • 31
    Bisgard C, Sloth H, Keiding N, Juel K. Excess mortality in giant cell arteritis. J Intern Med 1991; 230: 11923.
  • 32
    Graham E, Holland A, Avery A, Russell RW. Prognosis in giant-cell arteritis. Br Med J (Clin Res Ed) 1981; 282: 26971.